Cardiac SPECT

Single photon emission computed tomography (SPECT) is a nuclear imaging modality that uses injected radiotracers to image heart cell metabolism to show functional information on the heart. Cardiac SPECT is used for myocardial perfusion imaging (MPI) and represents the vast majority of nuclear cardiologic imaging exams each year. It is used to determine if a patient has ischemia or an infarct and if revascularization of the coronary arteries will help the patient experiencing chest pain or a heart attack. The FDA has approved four radiotracers for MPI, including thallium-201, 99mTc-Sestamibi, 99mTc-Tetrofosmin, and 99mTc-Teboroxime.

Thumbnail

Combining AI with cardiac imaging helps predict heart attacks, cardiovascular deaths

The findings were presented virtually during the Society of Nuclear Medicine and Molecular Imaging's 2021 Annual Meeting.

Thumbnail

Imaging advocates offer guidance after reported spate of SPECT/CT payment denials

The Society of Nuclear Medicine & Molecular Imaging said it’s received “many complaints” from the field pertaining to various commercial payers. 

chest pain lung pulmonary embolism

CCTA is a safe, effective alternative to SPECT in patients with stable chest pain

The findings come by way of the RESCUE Trial, which included more than 1,000 participants from 44 different sites.

Thumbnail

ASNC monitoring potential Mo-99 supply shortages due to COVID-19

The president of the American Society of Nuclear Cardiology said there are no shortfalls reported at this time, but the organization is keeping an eye on the situation as more countries implement travel bans.

Thumbnail

SNMMI backs updated ASNC guidelines on SPECT MPI

New 2018 guidelines for myocardial perfusion imaging (MPI) protocols on conventional and novel single photon emission computed tomography (SPECT) for nuclear cardiology practitioners has received praise from the Society for Nuclear Medicine and Molecular Imaging (SNMMI).

UltraSPECT and ASNC partner to provide technologist travel awards to attend ASNC2014

UltraSPECT, provider of the most cost-effective solutions for meeting American Society of Nuclear Cardiology (ASNC) guidelines for low dose nuclear medicine imaging, announces today its support of nuclear medicine technologists via six new grants.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.